Alterations in microRNA expression linked to microcystin-LR-induced tumorigenicity in human WRL-68 Cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 743, Issue 1-2, 2012, Pages 75-82

  Xu, Lizhi ^a   Qin, Wendi ^b   Zhang, Huan ^a   Wang, Yucai ^c   Dou, Huan ^a   Yu, Decai ^a   Ding, Yitao ^a   Yang, Liuyan ^b   Wang, Yaping ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Environmental inspection; Microcystin LR; MiRNA; Tumorigenicity

Indexed keywords

MICROCYSTIN; MICRORNA; MICRORNA 122; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; GROWTH RATE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CARCINOGENS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LIVER; MICE; MICE, NUDE; MICROCYSTINS; MICRORNAS; WATER POLLUTANTS;

MUS MUSCULUS;

EID: 84862779614     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.12.024     Document Type: Article

References (52)

1. Eriksson J.E., Paatero G.I., Meriluoto J.A., Codd G.A., Kass G.E., Nicotera P., Orrenius S. Rapid microfilament reorganization induced in isolated rat hepatocytes by microcystin-LR, a cyclic peptide toxin. Exp. Cell Res. 1989, 185:86-100.
2. Mereish K.A., Solow R. Effect of antihepatotoxic agents against microcystin-LR toxicity in cultured rat hepatocytes. Pharm. Res. 1990, 7:256-259.
3. Ueno Y., Nagata S., Tsutsumi T., Hasegawa A., Watanabe M.F., Park H.D., Chen G.C., Chen G., Yu S.Z. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis 1996, 17:1317-1321.
4. Chen J., Xie P. Seasonal dynamics of the hepatotoxic microcystins in various organs of four freshwater bivalves from the large eutrophic lake Taihu of subtropical China and the risk to human consumption. Environ. Toxicol. 2005, 20:572-584.
5. Poste A.E., Hecky R.E., Guildford S.J. Evaluating microcystin exposure risk through fish consumption. Environ. Sci. Technol. 2011, 45(13):5806-5811.
6. Carmichael W.W., Azevedo S.M., An J.S., Molica R.J., Jochimsen E.M., Lau S., Rinehart K.L., Shaw G.R., Eaglesham G.K. Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins. Environ. Health Perspect. 2001, 109:663-668.
7. Li Y., Chen J.A., Zhao Q., Pu C., Qiu Z., Zhang R., Weiqun S. A Cross-Sectional Investigation of Chronic Exposure to Microcystin in Relationship to Childhood Liver Damage in the Three Gorges Reservoir Region. China Environ. Health Perspect 2011, 119(10):1483-1488.
8. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992, 15:948-963.
9. EL-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
10. de La Coste A., Romagnolo B., Billuart P., Renard C.A., Buendia M.A., Soubrane O., Fabre M., Chelly J., Beldjord C., Kahn A., Perret C. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8847-8851.
11. Lunn R.M., Zhang Y.J., Wang L.Y., Chen C.J., Lee P.H., Lee C.S., Tsai W.Y., Santella R.M. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 1997, 57:3471-3477.
12. Jiang J., Gusev Y., Aderca I., Mettler T.A., Nagorney D.M., Brackett D.J., Roberts L.R., Schmittgen T.D. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. 2008, 14:419-427.
13. Ladeiro Y., Couchy G., Balabaud C., Bioulac-Sage P., Pelletier L., Rebouissou S., Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008, 47:1955-1963.
14. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
15. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
16. Robins H., Li Y., Padgett R.W. Incorporating structure to predict microRNA targets. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4006-4009.
17. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19(1):92-105.
18. Zhang B., Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ. Health Perspect. 2009, 117:231-240.
19. Jardim M.J., Fry R.C., Jaspers I., Dailey L., Diaz-Sanchez D. Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ. Health Perspect. 2009, 117(11):1745-1751.
20. Izzotti A., Calin G.A., Arrigo P., Steele V.E., Croce C.M., De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009, 23(3):806-812.
21. Hou L., Wang D., Baccarelli A. Environmental chemicals and microRNAs. Mutat. Res. 2011, 714(1-2):105-112.
22. Perdomo C., Spira A., Schembri F. MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis. Mutat. Res. 2011, 717(1-2):32-37.
23. Sonkoly E., Pivarcsi A. MicroRNAs in inflammation and response to injuries induced by environmental pollution. Mutat. Res. 2011, 717(1-2):46-53.
24. Rager J.E., Smeester L., Jaspers I., Sexton K.G., Fry R.C. Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells. Environ. Health Perspect. 2011, 119(4):494-500.
25. Pogribny I.P., Tryndyak V.P., Boyko A., et al. Induction of microRNAome deregulation in rat liver by longterm tamoxifen exposure. Mutat. Res. 2007, 619:30-37.
26. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
27. Wang Y., Lee A.T., Ma J.Z., Wang J., Ren J., Yang Y., Tantoso E., Li K.B., Ooi L.L., Tan P., Lee C.G. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J. Biol. Chem. 2008, 283:13205-13215.
28. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
29. Huang Y.S., Dai Y., Yu X.F., Bao S.Y., Yin Y.B., Tang M., Hu C.X. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J. Gastroenterol. Hepatol. 2008, 23:87-94.
30. Meng F.Y., Henson R., Janek H.W., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
31. Strick-Marchand H., Weiss M.C. Embryonic liver cells and permanent lines as models for hepatocyte and bile duct cell differentiation. Mech. Dev. 2003, 120:89-98.
32. Gutierrez-Ruiz M.C., Bucio L., Souza V., Gomez J.J., Campos C., Carabez A. Expression of some hepatocyte-like functional properties of WRL-68 cells in culture. In Vitro Cell Dev. Biol. Anim. 1994, 30A:366-371.
33. van Apeldoorn M.E., van Egmond H.P., Speijers G.J.A., Bakker G.J.I. Toxins of cyanobacteria. Mol. Nutr. Food Res. 2007, 51:7-60.
34. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafre S.A., Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 2007, 282:23716-23724.
35. Kutay H., Bai S., Datta J., Motiwala T., Pogribny I., Frankel W., Jacob S.T., Ghoshal K. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell. Biochem. 2006, 99:671-678.
36. Fornari F., Gramantieri L., Ferracin M., Veronese A., Sabbioni S., Calin G.A., Grazi G.L., Giovannini C., Croce C.M., Bolondi L., Negrini M. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008, 27:5651-5661.
37. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., Xu C., Mason W.S., Moloshok T., Bort R., et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004, 1:106-113.
38. Fornari F., Gramantieri L., Giovannini C., Veronese A., Ferracin M., Sabbioni S., Calin G.A., Grazi G.L., Croce C.M., Tavolari S., et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009, 69:5761-5767.
39. Gramantieri L., Ferracin M., Fornari F., Veronese A., Sabbioni S., Liu C.G., Calin G.A., Giovannini C., Ferrazzi E., Grazi G.L., et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007, 67:6092-6099.
40. Coulouarn C., Factor V.M., Andersen J.B., Durkin M.E., Thorgeirsson S.S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536.
41. Kimura S.H., Ikawa M., Ito A., Okabe M., Nojima H. Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery. Oncogene 2001, 20:3290-3300.
42. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 2001, 270(1-2):1-15.
43. Michl P., Ramjaun A.R., Pardo O.E., Warne P.H., Wagner M., Poulsom R., D'Arrigo C., Ryder K., Menke A., Gress T., Downward J. CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 2005, 7(6):521-532.
44. Truscott M., Raynal L., Premdas P., Goulet B., Leduy L., Bérubé G., Nepveu A. CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter. Mol. Cell. Biol. 2003, 23(8):3013-3028.
45. Ripka S., Neesse A., Riedel J. CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. GUT 2010, 59(8):1101-1110.
46. Xu Hui, He Jie-Hua, Xiao Zhen-Dong Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 2010, 52(4):1431-1442.
47. Lei W.W., Zhang K.H., Pan X.C., Wang D.M., Hu Y., Yang Y.N., Song J.G. Histone deacetylase 1 and 2 differentially regulate apoptosis by opposing effects on extracellular signal-regulated kinase 1/2. Cell Death Dis. 2010, 20(1):e44.
48. Osborne T.F. CREating a SCAP-less liver keeps SREBPs pinned in the ER membrane and prevents increased lipid synthesis in response to low cholesterol and high insulin. Genes Dev. 2001, 15:1873-1878.
49. Bengoechea-Alonso M.T., Punga T., Ericsson J. Hyperphosphorylation regulates the activity of SREBP1 during mitosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11681-11686.
50. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15524-15529.
51. Wiemer E.A. The role of microRNAs in cancer: no small matter. Eur. J. Cancer 2007, 43:1529-1544.
52. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-3756.